Nal-anti TIGIT bi-functional ADC (TuHURA Biosciences)

N/A

Report date: 2025/06/11 11:25:01

Base Information

Drug NameNal-anti TIGIT bi-functional ADC (TuHURA Biosciences)

Drug Alias NameTIGT- targeting antibody.drug conjugate (TuHURA Biosciences)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionT cell immunoglobulin and ITIM domains modulators

TargetsT cell immunoglobulin and ITIM domains

Therapy Area/IndicationsMyelodysplastic Syndromes

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKintara Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesKintara Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsMyelodysplastic Syndromes

Inactive IndicationsN/A

Other Information

ATC CodeN/A